openPR Logo
Press release

Surge In Smoking Addiction To Drive Growth In Varenicline Market: Key Factor Driving The Growth In The Varenicline Market

06-02-2025 08:59 AM CET | Health & Medicine

Press release from: The Business Research Company

Varenicline

Varenicline

The Varenicline Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Expected Varenicline Market Size During the Forecast Period?
The varenicline market has seen strong growth in recent years. It is projected to rise from $1.7 billion in 2024 to $1.81 billion in 2025, with a CAGR of 6.6%. The historic growth is due to the increasing efforts in smoking cessation programs, regulatory approvals and recommendations, the effectiveness and safety of varenicline, greater research and development, and the growing prevalence of smoking-related diseases.

The varenicline market is expected to grow to $2.3 billion by 2029 at a CAGR of 6.2%, fueled by advancements in smoking cessation research and increased focus on personalized medicine. Key trends include the integration of digital health technologies, combination therapies, government support, and expanded insurance coverage for smoking cessation.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18493

What Are the High-Growth Segments in the Varenicline Market?
The varenicline market covered in this report is segmented -

1) By Type: 0.5 Mg Tablets, 1 Mg Tablets
2) By Route Of Administration: Oral, Sublingual, Transdermal
3) By Patient Type: Smokers, Ex Smokers, Pre Quitters
4) By Application: Hospital, Drug Store

Subsegments:
1) By 0.5 mg Tablets: Branded 0.5 mg Varenicline Tablets, Generic 0.5 mg Varenicline Tablets
2) By 1 mg Tablets: Branded 1 mg Varenicline Tablets, Generic 1 mg Varenicline Tablets

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18493&type=smp

What Key Drivers Are Expected to Influence Future Varenicline Market Growth?
The growing prevalence of smoking addiction is expected to boost the growth of the varenicline market. Smoking addiction, driven by social influences and easy access to tobacco products, is rising, especially among younger populations. Varenicline is a medication designed to help people quit smoking by reducing cravings and withdrawal symptoms. According to Statistics Canada, cigarette production and sales increased in 2022. The rising smoking addiction is driving the demand for varenicline.

Which Companies Hold the Largest Share Across Different Varenicline Market Segments?
Major companies operating in the varenicline market are Pfizer Inc., Biocon Limited, Oyster Point Pharma Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Sandoz International GmbH, Nanjing Clasien Pharmaceutical & Chemical Co. Ltd., Hetero Drugs Limited, Sun Pharmaceutical Industries Ltd, Aurobindo Pharma Limited, Dr. Reddy's Laboratories Ltd., Cipla Limited, Apotex Inc, Amneal Pharmaceuticals LLC, Lupin Limited, Alkem Laboratories Ltd, Glenmark Pharmaceuticals Limited, Jubilant Life Sciences Limited, Alembic Pharmaceuticals Limited, Torrent Pharmaceuticals Ltd., Medley Pharmaceuticals Ltd, Wockhardt Ltd, Par Pharmaceutical Inc, Torrent Pharmaceuticals Ltd, Cadila Healthcare Limited (Zydus Cadila), Lee Pharma Limited, Viwit Pharmaceuticals Limited, Leading Pharma LLC

What Are the Major Trends Shaping the Varenicline Market?
Companies in the varenicline market are working on new formulations and delivery methods, like generic tablets, to expand their market presence. Generic varenicline tablets are non-branded alternatives to branded medications for smoking cessation. For instance, in January 2024, Lupin Limited, an India-based pharmaceutical company, launched generic varenicline tablets in the US. These tablets, available in 0.5 mg and 1 mg strengths, are designed to assist in smoking cessation therapy and are bioequivalent to Chantix tablets.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/varenicline-global-market-report

What Are the Emerging Geographies for The Varenicline Market Growth?
North America was the largest region in the varenicline market in 2024. The regions covered in the varenicline market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Varenicline Market?
2. What is the CAGR expected in the Varenicline Market?
3. What Are the Key Innovations Transforming the Varenicline Industry?
4. Which Region Is Leading the Varenicline Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Surge In Smoking Addiction To Drive Growth In Varenicline Market: Key Factor Driving The Growth In The Varenicline Market here

News-ID: 4046157 • Views:

More Releases from The Business Research Company

Global Ultrafast Laser Technology Market Outlook 2025-2034: Trends, Innovations, And Future Outlook
Global Ultrafast Laser Technology Market Outlook 2025-2034: Trends, Innovations, …
The Ultrafast Laser Technology Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Ultrafast Laser Technology Market Size and Projected Growth Rate? The ultrafast laser technology market will grow from $2.28 billion in 2024 to $2.55 billion in 2025 at a CAGR of 12.1%.
Industrialization Fuels Growth In The Water Treatment Chemicals Market: A Key Driver Powering Water Treatment Chemicals Market Growth In 2025
Industrialization Fuels Growth In The Water Treatment Chemicals Market: A Key Dr …
The Water Treatment Chemicals Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Current Water Treatment Chemicals Market Size and Its Estimated Growth Rate? The water treatment chemicals market will expand from $35.77 billion in 2024 to $37.82 billion in 2025, reflecting a CAGR
Tumor Ablation Market Size Forecasted To Achieve $2.54 Billion By 2029 With Steady Growth
Tumor Ablation Market Size Forecasted To Achieve $2.54 Billion By 2029 With Stea …
The Tumor Ablation Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Tumor Ablation Market Size and Projected Growth Rate? The tumor ablation market will grow from $1.45 billion in 2024 to $1.62 billion in 2025, with a CAGR of 12.1%. The growth in
Water Cooled Capacitors Market Report 2025-2034: Industry Overview, Trends, And Forecast Analysis
Water Cooled Capacitors Market Report 2025-2034: Industry Overview, Trends, And …
The Water Cooled Capacitors Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Current Water Cooled Capacitors Market Size and Its Estimated Growth Rate? The water cooled capacitors market will expand from $0.79 billion in 2024 to $0.86 billion in 2025 at a CAGR

All 5 Releases


More Releases for Varenicline

Addictions Therapeutics Market worth USD 10,735.94 million by 2027 - Exclusive R …
According to our latest study on "Addictions Therapeutics Market Forecast to 2027 - COVID-19 Impact and Analysis - by Treatment Type, Drug Type, Treatment Center, and Distribution Channel," the market was valued at US$ 6,691.01 million in 2019 and is projected to reach US$ 10,735.94 million by 2027; it is expected to grow at a CAGR of 6.2% from 2020 to 2027. The report highlights trends prevailing in the global
Global Varenicline Market Analysis with Research Report 2022 |: Pfizer, Apotex
The Global Varenicline Market Report is a valuable source of insightful data for business strategists. It provides the industry overview with growth analysis and historical & futuristic cost, revenue, demand, and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Market study provides comprehensive data that enhances the understanding, scope, and application of this report. Top Key Players in the Global Varenicline
08-04-2021 | Health & Medicine
Fact.MR
Sales Forecast of Varenicline Addiction Treatment Market , Analysis, and Forecas …
It is estimated that more than 8 million people die due to tobacco consumption. Cigarette smoking is the leading cause of lung cancers and various cardiovascular diseases. Increased cigarette smoking has prompted governments to initiate awareness campaigns to desist individuals from the habit. Moreover, introduction of de-addiction methods have greatly helped curb the menace of smoking. On the back of this, the global addiction treatment market is anticipated to expand
02-12-2021 | Health & Medicine
Fact.MR
Global Addiction Treatment Market to Show Robust Growth | Alkermes, Purdue Pharm …
Research studies conducted on the safety of varenicline are promoting awareness amongst smoking addicts, stating that the medication is less likely to result in cardiovascular or neuropsychiatric hospitalization. As such, quit-smoking products are being approved by the U.S. Food and Drug Association (FDA). These improvements in medications are bolstering growth for the addiction treatment market, which is poised to register a favourable CAGR of 6.7% during the assessment period of
Stay Tuned with the Epic Battle in the Smoking Cessation and Nicotine De-Addicti …
HTF MI recently introduced Global and Regional Smoking Cessation and Nicotine De-Addiction Products Market study with in-depth overview, describing about the Product / Industry Scope and elaborates market outlook and status to 2023. The market Study is segmented by key regions which is accelerating the marketization. At present, the market is developing its presence and some of the key players from the complete study are Cipla Ltd., GlaxoSmithKline plc, Imperial
Smoking Cessation Nicotine De Addiction Products Market Focusing On Pfizer, Inc, …
North America is expected to remain the most lucrative market for smoking cessation and nicotine de-addiction products, with sales estimated to reach revenues worth US$ 10,259.5 Mn by 2025-end. In North America, innovative players in nicotine replacement therapy (NRT) are focusing on introduction of novel treatment alternatives including selective partial agonists of nicotine receptors (varenicline), and Tabex (cytosine plant-based alkaloid). In addition, MPOWER initiative taken by the WHO has successfully